Eastman Chemical (EMN) Q4 Earnings: What's in the Cards?

Eastman ChemicalEMN is set to release fourth-quarter 2016 results after the bell on Jan 26.

The company saw lower profits in the third quarter of 2016 as its sales fell on reduced selling prices. Adjusted earnings of $1.86 per share in the quarter topped the Zacks Consensus Estimate of $1.67. Revenues fell around 7% year over year to $2,287 million mainly due to lower prices and reduced Fibers sales volume that more than offset higher sales volume in other segments. Sales missed the Zacks Consensus Estimate of $2,308 million.

Eastman Chemical has beaten the Zacks Consensus Estimate in three of the trailing four quarters with an average beat of 5.99%. Let's see how things are shaping up prior to this announcement.

Factors to Consider

Eastman Chemical, in its third-quarter earnings call, said that it is benefiting from strong growth of its high value products and its cost-cutting actions. The company sees adjusted earnings for 2016 in the band of $6.70 and $6.80 per share.

The company expects to deliver at least $100 million of costs savings for full-year 2016 and an additional $100 million in 2017. The company also recently hiked its quarterly dividend for the seventh consecutive year.

Eastman Chemical remains focused on cost-cutting and productivity actions amid a challenging operating environment. Moreover, Eastman Chemical remains committed to reduce debt and boost shareholder returns leveraging healthy free cash flows.

The company should also gain from its strategic acquisitions and capacity expansion actions. The acquisition of Solutia boosted its presence in the emerging markets and offer growth opportunities in Asia Pacific. The acquisition of BP Plc's aviation turbine engine oil business has enabled Eastman Chemical to better address the needs of the global aviation industry. Moreover, the purchase of Taminco Corporation has reinforced the company's foothold in attractive niche end-markets including food, feed and agriculture where Taminco has a strong presence. The acquisition has also provided attractive cost and revenue synergy opportunities.

In Sep 2014, Eastman completed the expansion of Eastman Chemical 168 non-phthalate plasticizer by roughly 15%. With capacity expansion, the company will be able to serve the growing needs of non-phthalate plasticizers worldwide.

Eastman Chemical has outperformed the Zacks categorized Chemicals-Diversified industry over the past three months. The company's shares have gained around 14.7% over this period, compared with roughly 8.5% gain recorded by the industry.

However, Eastman Chemical continues to see pricing pressure across its business segments, especially in the Chemical Intermediates unit, as witnessed in the third quarter. The company is seeing increased competitive pressure, especially from the Asia Pacific region, which is hurting prices. Moreover, challenging global economic conditions are affecting demand for some of the company's products. The company also faces currency translation risk.

Eastman Chemical Co. Price and Consensus

Eastman Chemical Co. Price and Consensus | Eastman Chemical Co. Quote

Earnings Whispers

Our proven model does not conclusively show that Eastman Chemical is likely to beat estimates this quarter. This is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. This is not the case here, as you will see below:

Zacks ESP : The Earnings ESP for Eastman Chemical is -2.03% as the Most Accurate estimate stands at $1.45 while the Zacks Consensus Estimate is pegged at $1.48. You can uncover the best stocks to buy or sell before they're reported with our Earnings ESP Filter .

Zacks Rank : Eastman Chemical currently carries a Zacks Rank #3 which when combined with a negative ESP, makes surprise prediction difficult.

We caution against stocks with a Zacks Rank #4 or 5 (Sell rated) going into the earnings announcement, especially when the company is seeing negative estimate revisions.

Stocks to Consider

Here are some companies in the chemical industry you may want to consider as our model shows these have the right combination of elements to post an earnings beat this quarter:

The Methanex Corporation MEOH has an Earnings ESP of +53.33% and a Zacks Rank #1.

Albermale Corporation ALB has an Earnings ESP of +2.67% and a Zacks Rank #2.

Celanese Corporation CE has an Earnings ESP of + 0.66% and a Zacks Rank #2.

Zacks' Top Investment Ideas for Long-Term Profit

How would you like to see our best recommendations to help you find today's most promising long-term stocks? Starting now, you can look inside our portfolios featuring stocks under $10, income stocks, value investments and more. These picks, which have double and triple-digit profit potential, are rarely available to the public. But you can see them now. Click here >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Eastman Chemical Co. (EMN): Free Stock Analysis Report

Methanex Corp. (MEOH): Free Stock Analysis Report

Albemarle Corp. (ALB): Free Stock Analysis Report

Celanese Corp. (CE): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Other Topics

Earnings Stocks

Latest Markets Videos


    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at

    Learn More